Thailand plans November human testing for potential coronavirus vaccine

Bangkok

Thai researchers plan to begin human trials of a potential vaccine for the new coronavirus in November and are preparing 10,000 doses, a senior official said on Sunday, aiming for a vaccine that could be ready for use by late next year. Following favourable results in trials on primates, the next step is to manufacture doses for human trials, said Kiat Ruxrungtham, director of the Bangkok’s Chulalongkorn University vaccine development program.

“At first we were going to send them in June, but it was not easy to plan everything,” Kiat told a news conference. There are no approved vaccines for the virus that causes COVID-19, but 19 candidates are being trailed in humans globally. China is leading the race, with an experimental vaccine by Sinovac Biotech Ltd.

Thailand’s first facility should complete production in October and send the products to a second facility, which should finish by November, he said. Originally the earliest target was September, but Kiat said not enough vaccine can be ready by then. Facilities in San Diego and Vancouver will produce 10,000 doses for the trials for 5,000 people. The first group, aged 18 to 60, will receive different doses of the vaccine, he said.